These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18510489)

  • 41. Metabolic syndrome and its characteristics among obese patients attending an obesity clinic.
    Termizy HM; Mafauzy M
    Singapore Med J; 2009 Apr; 50(4):390-4. PubMed ID: 19421683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic syndrome in hypertensive patients: correlation between anthropometric data and laboratory findings.
    Bulhões K; Araújo L
    Diabetes Care; 2007 Jun; 30(6):1624-6. PubMed ID: 17351284
    [No Abstract]   [Full Text] [Related]  

  • 43. Metabolic syndrome and renal disease.
    Gluba A; Mikhailidis DP; Lip GY; Hannam S; Rysz J; Banach M
    Int J Cardiol; 2013 Apr; 164(2):141-50. PubMed ID: 22305775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic syndrome and chronic kidney disease: a Japanese perspective on a worldwide problem.
    Iseki K
    J Nephrol; 2008; 21(3):305-12. PubMed ID: 18587718
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Obesity and the metabolic syndrome in the elderly--a mini-review.
    Lechleitner M
    Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pulse pressure and the metabolic syndrome in patients with hypertension.
    Barrios V; Escobar C; Echarri R; Matalí A
    J Cardiometab Syndr; 2009; 4(2):72-5. PubMed ID: 19614792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiovascular risk assessment beyond Systemic Coronary Risk Estimation: a role for organ damage markers.
    Volpe M; Battistoni A; Tocci G; Rosei EA; Catapano AL; Coppo R; del Prato S; Gentile S; Mannarino E; Novo S; Prisco D; Mancia G
    J Hypertens; 2012 Jun; 30(6):1056-64. PubMed ID: 22573072
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gout, diet, and the insulin resistance syndrome.
    Fam AG
    J Rheumatol; 2002 Jul; 29(7):1350-5. PubMed ID: 12136887
    [No Abstract]   [Full Text] [Related]  

  • 49. Metabolic syndrome: a new view of some familiar transplant risks.
    Perkins JD
    Liver Transpl; 2006 Mar; 12(3):485-6. PubMed ID: 16498649
    [No Abstract]   [Full Text] [Related]  

  • 50. [Hypertension: early detection of target organ damage].
    Heim A; Pasche A; Feihl F; Liaudet L; Waeber B
    Rev Med Suisse; 2007 Sep; 3(124):1996, 1999-2002. PubMed ID: 17955826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subclinical organ damage and cardiovascular risk prediction.
    Sehestedt T; Olsen MH
    Blood Press; 2010 Jun; 19(3):132-9. PubMed ID: 20429694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiovascular and renal complications in patients with resistant hypertension.
    Muxfeldt ES; de Souza F; Margallo VS; Salles GF
    Curr Hypertens Rep; 2014 Sep; 16(9):471. PubMed ID: 25079852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evolving importance of kidney disease: from subspecialty to global health burden.
    Eckardt KU; Coresh J; Devuyst O; Johnson RJ; Köttgen A; Levey AS; Levin A
    Lancet; 2013 Jul; 382(9887):158-69. PubMed ID: 23727165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic syndrome and left ventricular dysfunction: new player of the game.
    Celik T; Iyisoy A; Yuksel UC; Jata B; Gungor M
    Int J Cardiol; 2010 Jan; 138(2):209-11. PubMed ID: 18676045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Population models in the study of the neurogenic determinants of arterial hypertension. Report I. Peculiarities of arterial hypertension in schizophrenia].
    Tret'iakov AIu; Zakharchenko SP; Smirnova OI; Khoshchenko IuA; Grigorenko AL
    Klin Med (Mosk); 2007; 85(11):31-6. PubMed ID: 18219952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pulmonary venous flow: adding prognostic significance to diastolic dysfunction.
    Muiesan ML
    J Hypertens; 2008 Apr; 26(4):636-8. PubMed ID: 18327069
    [No Abstract]   [Full Text] [Related]  

  • 57. The metabolic syndrome and its relationship to hypertensive target organ damage.
    Mulè G; Cerasola G
    J Clin Hypertens (Greenwich); 2006 Mar; 8(3):195-201. PubMed ID: 16522997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Steroid resistant nephrotic syndrome recent developments.
    Bagga A
    Indian Pediatr; 2006 Jan; 43(1):9-13. PubMed ID: 16465000
    [No Abstract]   [Full Text] [Related]  

  • 59. Dietary sodium: the dark horse amongst cardiovascular and renal risk factors.
    Mimran A; du Cailar G
    Nephrol Dial Transplant; 2008 Jul; 23(7):2138-41. PubMed ID: 18456679
    [No Abstract]   [Full Text] [Related]  

  • 60. [Proven and new parameters of hypertensive target organ damage].
    Schmidt BM; Schmieder RE
    Dtsch Med Wochenschr; 2006 Nov; 131(46 Spec No):H20-3. PubMed ID: 17109244
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.